How the 4 Biggest Health Insurance Companies Control Your Care

97% of metropolitan areas in the United States have highly concentrated health insurance markets. That is not a typo. According to the American Medical Association's 2024 competition study, nearly every metro area in America fails the federal government's own standard for a competitive marketplace. (Source: AMA Competition in Health Insurance, 2024)

Four corporations---UnitedHealth Group, Elevance Health, CVS Health/Aetna, and The Cigna Group---control 49% of the national commercial health insurance market (employer and individual plans, not counting Medicare or Medicaid). In nearly half of all metro areas, a single insurer holds majority market share. And year after year, the market gets more concentrated, not less.

Here's who they are, what they own, and how their dominance affects your premiums, your claims, and your access to care.

The Big 4: Who Controls US Health Insurance

The four largest health insurers in America are not just insurance companies. They are sprawling conglomerates that own physician practices, pharmacy benefit managers (the middlemen who control your prescription drug pricing), data processing companies, and retail pharmacies. Understanding what they own is the first step to understanding why your premiums keep rising.

1. UnitedHealth Group

Revenue: $447.6 billion (2025). Members: 49.8 million. National commercial market share: 16%.

The largest healthcare company on Earth. Through Optum, UnitedHealth employs or is affiliated with 90,000 physicians, operates OptumRx (Big Three PBM), and processes one in three patient records in America through Change Healthcare. Read our full analysis of the UnitedHealth-Optum monopoly.

2. Elevance Health (Formerly Anthem)

Revenue: $197.6 billion (2025). Members: 45.2 million. National commercial market share: 12%.

You may not recognize the name---Elevance rebranded from Anthem in 2022---but its health plans still operate as Anthem Blue Cross Blue Shield in 14 states. Subsidiaries include Carelon (health services and PBM) and Wellpoint (Medicaid). Elevance is the dominant insurer in 82 US metro areas.

3. CVS Health / Aetna

Revenue: $402.1 billion (2025). Members: 26.6 million. National commercial market share: 12%.

One company controls your insurance (Aetna), your PBM (CVS Caremark---the largest in the US), and your pharmacy (9,600+ CVS locations). See our breakdown of CVS-Aetna's anti-competitive effects.

4. The Cigna Group

Revenue: $274.9 billion (2025). Members: 18.1 million. National commercial market share: 9%.

About 85% of Cigna's revenue comes not from insurance but from Evernorth Health Services, which includes Express Scripts---the second-largest PBM. Cigna sold its Medicare Advantage business to HCSC in March 2025.

Big 4 at a Glance

Sources: Company Q4 2025 earnings; AMA Competition in Health Insurance 2024

Combined, these four companies collected $1.322 trillion in revenue in 2025 and controlled 49% of the national commercial market. Three of the four own their own PBMs, giving them control over both insurance coverage decisions and prescription drug pricing---a conflict of interest the FTC has investigated. (Source: FTC Interim Report on PBMs, 2024)

For more on how PBMs owned by insurers inflate your drug costs, see our guide on 4 schemes driving up your prescription costs.

The top 10 insurers control 72% of the national market. Everyone else---hundreds of smaller plans---splits the remaining 28%.

Regional Monopolies: Where One Insurer Controls Your Market

By the federal government's own standard for market competition, the average US metro health insurance market is nearly double the threshold for "highly concentrated." And it's been getting worse---concentration increased steadily from 2011 to 2022. (Source: GAO-25-107194, November 2024)

The AMA's study of 384 metro areas shows how this plays out: (Source: AMA Competition in Health Insurance, 2024)

• In 47% of metro areas, a single insurer holds 50% or more market share
• In 91% of metro areas, one insurer holds 30% or more
• BCBS-affiliated insurers dominate 84% of metro areas

Some states are effectively insurance monopolies:

These aren't outliers. In 18 states, one insurer controls 75% or more of the large-group market. If you live in Alabama, Kentucky, Hawaii, Michigan, Louisiana, Illinois, Alaska, Vermont, Delaware, or West Virginia, your employer likely has one realistic option for group coverage. "Choice" is a fiction.

Notice how many of those dominant insurers carry the Blue Cross Blue Shield name. BCBS isn't one company---it's a federation of roughly three dozen independent insurers that license the brand and agree not to compete in each other's territories. Combined, they cover about one in three Americans. The franchise structure delivers the market power of a national monopoly while maintaining the legal appearance of separate companies. We'll have a full breakdown of how the BCBS model works in an upcoming article.

The pattern holds for Medicare Advantage, where 97% of markets are highly concentrated and UnitedHealth alone dominates 44% of metro areas. Rural areas are hit hardest---some counties have one or two insurers, sometimes zero on the ACA marketplace. When a single company controls the market, there's no competitive pressure to lower premiums, expand networks, or improve service.

What This Costs You

Concentrated markets don't just limit choices. They raise prices, restrict access, and tilt the playing field against patients.

Higher Premiums

The relationship between concentration and cost is well-documented. When fewer insurers compete, premiums go up.

The National Bureau of Economic Research has found that hospital mergers---enabled by insurer market power that reduces bargaining counterweights---lead to premium increases and reduced worker pay. The mechanism is straightforward: in concentrated markets, insurers face less pressure to negotiate hard on your behalf because you have nowhere else to go. (Source: NBER, via GAO Blog)

Researchers at USC and the National Bureau of Economic Research found that when big insurers merged with PBMs, insurers that didn't own their own PBM saw premiums climb 36% higher than those that did. When the biggest players lock up the supply chain, everyone else pays more. (Source: USC Schaeffer Center, 2023)

UnitedHealthcare's 11% premium increase for 2026 employer plans is happening in this context---the company already dominates its markets and faces little competitive pressure to hold prices down. (Source: BenefitsPro, October 2025)

For more on how these cost increases affect ACA marketplace shoppers specifically, see our analysis of why ACA premiums jumped 21% in 2026.

Higher Denial Rates in Monopoly Markets

Market power doesn't just affect your premium. It affects whether your claims get paid.

Consider Alabama. Blue Cross Blue Shield of Alabama holds 94% of the large-group market---the most dominant position in the country. In 2023, BCBSAL also had a 34% in-network claim denial rate---the highest in the nation. (Source: TIME, 2025)

Now compare that to neighboring Mississippi, where a single insurer holds 81% of the market---still extremely concentrated, but slightly less so. Mississippi's denial rate: 15%. (Source: TIME, 2025)

One data point doesn't prove causation. But the pattern is consistent with what economists predict: when patients have no alternative, insurers face no consequences for aggressive denial practices. Where are you going to go?

If you've had a claim denied, you have more power than you think. Read our step-by-step guide to appealing insurance denials.

Narrower Networks and Provider Squeeze

When a dominant insurer controls 50%, 70%, or 94% of a market, it has enormous leverage over physicians and hospitals. Past AMA presidents have noted that dominant insurers have offered lower reimbursement rates than six years prior---paying doctors less even as the cost of running a medical practice increases. (Source: AMA via TIME, 2025)

Doctors in monopoly markets report spending 10-15 hours per week navigating prior authorization requirements from dominant insurers. That is time not spent treating patients. (Source: TIME, 2025)

The squeeze works in both directions. Insurers with market dominance can demand lower payments from providers while charging higher premiums to patients. The savings from low provider payments don't get passed to you---they become profit. The medical loss ratio (a rule requiring insurers to spend at least 80% of premiums on actual care) is supposed to prevent this, but in practice it leaves plenty of room for profit.

When Your Insurer Owns Everything

Market share alone doesn't capture the full picture. Three of the Big 4 insurers own their own PBMs:

• UnitedHealth owns OptumRx
• CVS/Aetna owns CVS Caremark (the largest PBM)
• Cigna owns Express Scripts (the second-largest PBM)

These three PBMs together control approximately 80% of US prescriptions. When the same company that decides whether your claim is covered also controls your prescription drug benefits, the conflicts of interest are structural. The FTC has investigated these conflicts and found PBMs marking up specialty generic drugs by "hundreds or even thousands of percent." (Source: FTC Report on Specialty Drug Markups, 2025)

UnitedHealth takes this further than anyone. It owns the insurance, the PBM, 90,000 physicians, and the data infrastructure (Change Healthcare) that processes claims for the entire industry---including its competitors. In a competitive market, rival offerings would keep this in check. In a market where UnitedHealth is already the largest player in 44% of Medicare Advantage markets and 16% of the employer/individual market, owning the entire supply chain just makes a monopoly worse.

The Consolidation Timeline: How We Got Here

The health insurance market didn't become concentrated overnight. It was built through decades of mergers, acquisitions, and regulatory failures.

Sources: Company filings; DOJ press releases; industry reporting

The Pattern Worth Noticing

In 2015, the DOJ blocked two mega-mergers---Anthem-Cigna and Aetna-Humana---on antitrust grounds. Regulators correctly identified that reducing the Big 5 to the Big 3 would harm consumers.

But after 2017, the regulatory posture shifted. The CVS-Aetna merger ($77B) was approved with minimal conditions. The Cigna-Express Scripts merger ($67B) sailed through. And in 2022, UnitedHealth's acquisition of Change Healthcare ($13B) was approved over the DOJ's own objections after a judge ruled the government hadn't proven its case.

The blocked mergers of 2015 were horizontal---one insurer buying another. The approved mergers of 2018-2022 were vertical---insurers buying companies in adjacent sectors (PBMs, data processors, pharmacies). Regulators treated vertical mergers as less threatening. The evidence since then---FTC investigations, billion-dollar markups, data breaches, premium increases---suggests that judgment was wrong.

What You Can Do

Market concentration is a systemic problem. But you are not powerless. Here are specific steps you can take today.

1. Check Your Bills for Overcharges

In a concentrated market, billing errors and overcharges are less likely to be caught because there's less competitive pressure for accuracy. Studies estimate Americans lose $88 billion annually to medical billing errors.

Request an itemized bill for every medical service. Compare charges to Medicare rates using our free bill analysis tool. Even in monopoly markets, you have the right to dispute charges that don't match what was agreed or what was medically provided.

2. Appeal Every Denial

Insurance companies in concentrated markets deny claims at higher rates because they can. In Medicare Advantage, the HHS Office of Inspector General found that insurers overturned 75% of their own denials when patients appealed---suggesting most denials shouldn't have been issued in the first place. (Source: HHS OIG)

Most patients never appeal. That's what insurers are counting on. Don't make it easy for them. Our complete guide to appealing insurance denials walks you through every step.

3. Understand Your Rights

Federal and state laws provide protections that insurers don't always volunteer:

• The No Surprises Act protects you from surprise out-of-network bills at in-network facilities
• Mental Health Parity Act requires equal coverage for mental health and substance use disorders
• State consumer protection laws vary but may provide additional billing dispute rights and external review processes

Read our complete Know Your Rights guide to understand what protections apply in your state.

4. Explore Alternatives During Open Enrollment

If your employer offers multiple plan options, compare them on more than just premium cost:

• Prior authorization requirements: How many hurdles does the plan put between you and care?
• Network breadth: How many providers are in-network? Does the plan include your preferred doctors and hospitals?
• Denial rates: Your state insurance commissioner's website often publishes complaint data by insurer
• Out-of-pocket maximums: In a concentrated market, the insurer has more leverage to shift costs to you through deductibles and copays

If you're on the ACA marketplace, look beyond the dominant insurer in your area. Smaller plans sometimes offer better value precisely because they're competing harder for members.

5. File Complaints

When you experience unfair billing, unexplained denials, or network restrictions that limit your access to care:

• Your state insurance commissioner: They regulate insurance practices and track complaints by insurer
• Your state attorney general: Many have active healthcare investigations
• The FTC: ftc.gov/complaint for anticompetitive behavior
• CMS: cms.gov for Medicare-related complaints
• The DOJ Antitrust Division: justice.gov/atr for antitrust violations

Individual complaints may feel insignificant. But regulators track complaint volumes, and patterns of complaints have triggered investigations---including the FTC's ongoing PBM probe.

6. Support Structural Reform

The most effective long-term solution is policy change:

• Strengthen antitrust enforcement: Block future healthcare mergers and consider unwinding vertical integration that has already occurred
• Expand price transparency requirements: Require insurers to disclose negotiated rates, denial rates, and network adequacy data
• Support state-level reforms: Several states have passed or are considering PBM reform, surprise billing protections, and insurance market competition requirements
• Push for a public option: A government-run insurance plan competing alongside private plans would provide a check on monopoly pricing in every market

Contact your federal and state representatives. Ask them specifically where they stand on health insurance market concentration.

Where This Leaves You

Four companies control half the health insurance in America. In most metro areas, a single insurer dominates. The market is getting more concentrated, not less. And every merger, every acquisition, every new subsidiary shifts more power from patients to corporations.

This is not an accident. It is the result of decades of approved mergers, weakened antitrust enforcement, and industry lobbying. The companies profiting from this system spent heavily to build it.

But concentrated markets also create accountability gaps. When one company controls your coverage, overcharges are harder to catch, denials are harder to fight, and billing errors are more likely to go unquestioned. That is exactly why tools that help patients review their bills independently exist---and why dominant insurers have no particular incentive to build them.

Start with what you can control. Check your bills. Appeal your denials. Understand what you're being charged and why. In a system designed to extract maximum revenue from patients, informed patients are the hardest to overcharge.

If your premiums went up, your claim was denied, or your bill doesn't look right---you're not alone. And you have more options than your insurer wants you to know about.